Sulfatidosis: Clinical Trials

6 trials for Sulfatidosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 not yet recruiting. 6 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 4, Not yet recruiting 2

Follow Sulfatidosis: new trials by email Literature Review of Sulfatidosis trials Research Report on Sulfatidosis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lentiviral Hematopoietic Stem Cell Gene Therapy for MLD
Lentiviral TYF-ARSA correction of patient's autologous HSCs - Metachromatic Leukodystrophy (MLD)
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute102027-06-012026-11-02
Direct Lentiviral Injection Gene Therapy for MLD
Intrathecal and intravenous LV gene therapy - Metachromatic Leukodystrophy (MLD)
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute102027-05-312026-11-02
Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders
Campath-1H, Clofarabine, Melphalan - Lysosomal Storage Disease, Peroxisomal Disorder
Not applicableCompletedMasonic Cancer Center, University of Minnesota32012-07-112017-12-05
Imaging Study of the White Matter Lesions in Children With Metachromatic Leucodystrophy
High-field MRI (3 Teslas) - Late Infantile Metachromatic Leukodystrophy
Not applicableCompletedAssistance Publique - Hôpitaux de Paris292010-11-012025-11-20
Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy
Warfarin - Metachromatic Leukodystrophy
Not applicableCompletedThe Cooper Health System102007-06-012011-03-21
Stem Cell Transplantation (SCT) for Genetic Diseases
Stem Cell Transplantation - Thrombocytopenia, Metachromatic Leukodystrophy
Not applicableCompletedNational Center for Research Resources (NCRR)1995-01-012005-06-24

Narrower conditions

Leukodystrophy, Metachromatic (6)  ·  Adrenoleukodystrophy (1)  ·  Anemia, Aplastic (1)  ·  Anemia, Diamond-Blackfan (1)  ·  Demyelinating Diseases (1)  ·  Fanconi Anemia (1)  ·  Gangliosidosis, GM1 (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Leukodystrophy, Globoid Cell (1)  ·  Lysosomal Storage Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucolipidoses (1)  ·  Mucopolysaccharidosis III (1)  ·  Peroxisomal Disorders (1)

Broader conditions

Brain Diseases (6)  ·  Brain Diseases, Metabolic (6)  ·  Brain Diseases, Metabolic, Inborn (6)  ·  Central Nervous System Diseases (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6)  ·  Hereditary Central Nervous System Demyelinating Diseases (6)  ·  Leukoencephalopathies (6)  ·  Lipid Metabolism Disorders (6)  ·  Lipid Metabolism, Inborn Errors (6)  ·  Lipidoses (6)  ·  Lysosomal Storage Diseases, Nervous System (6)  ·  Metabolic Diseases (6)  ·  Nervous System Diseases (6)  ·  Nutritional and Metabolic Diseases (6)

Interventions

Alemtuzumab (1)  ·  Clofarabine (1)  ·  Cyclosporine (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Melphalan (1)  ·  Mycophenolic Acid (1)  ·  Radiotherapy, Intensity-Modulated (1)  ·  Stem Cell Transplantation (1)  ·  Warfarin (1)  ·  Whole-Body Irradiation (1)

Sponsors

Shenzhen Geno-Immune Medical Institute (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  National Center for Research Resources (NCRR) (1)  ·  The Cooper Health System (1)

Countries

United States (3)  ·  China (2)  ·  France (1)

Top investigators

Caroline Sevin, MD, PhD (1)  ·  Lung-Ji Chang, Ph.D (1)  ·  Mitra Assadi, M.D. (1)  ·  Paola Leone, Ph.D. (1)  ·  Stephen A. Feig (1)  ·  Weston Miller, MD (1)